Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta‐analysis
Lauren M. Forgrave, Matthew Huei‐Ming, John R. Best, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2019) Vol. 11, Iss. 1, pp. 730-743
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
Alexis Moscoso, Michel J. Grothe, Nicholas J. Ashton, et al.
JAMA Neurology (2021) Vol. 78, Iss. 4, pp. 396-396
Open Access | Times Cited: 233
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
Nicholas J. Ashton, Antoine Leuzy, Yau Mun Lim, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 152
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
Whitley W. Aamodt, Teresa Waligórska, Junchao Shen, et al.
Movement Disorders (2021) Vol. 36, Iss. 12, pp. 2945-2950
Open Access | Times Cited: 120
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 110
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Federico Verde, Markus Otto, Vincenzo Silani
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 106
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
Simone Baiardi, Corinne Quadalti, Angela Mammana, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 103
The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease
Youjin Jung, Jessica S. Damoiseaux
Brain (2023) Vol. 147, Iss. 1, pp. 12-25
Open Access | Times Cited: 49
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 22
Surface-enhanced Raman scattering for the detection of biomarkers of neurodegenerative diseases: A review
Chentao Li, Yinglin Wang, Yafang Wu, et al.
TrAC Trends in Analytical Chemistry (2025) Vol. 185, pp. 118173-118173
Closed Access | Times Cited: 2
Diagnostic and prognostic value of serum NfL and p-Tau181in frontotemporal lobar degeneration
Alberto Benussi, Thomas K. Karikari, Nicholas J. Ashton, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 9, pp. 960-967
Open Access | Times Cited: 127
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
Elisabetta Zucchi, Valentina Bonetto, Gianni Sorarù, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 83
Blood Neurofilament Light Chain: The Neurologist’s Troponin?
Simon Thebault, Ronald A. Booth, Mark S. Freedman
Biomedicines (2020) Vol. 8, Iss. 11, pp. 523-523
Open Access | Times Cited: 78
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
Steffen Halbgebauer, Petra Steinacker, Federico Verde, et al.
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 93, Iss. 1, pp. 68-74
Closed Access | Times Cited: 64
Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis
Wei‐Ming Su, Yangfan Cheng, Zheng Jiang, et al.
EBioMedicine (2021) Vol. 74, pp. 103732-103732
Open Access | Times Cited: 63
Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges
Salomé Coppens, Sylvain Lehmann, Christopher Hopley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11624-11624
Open Access | Times Cited: 40
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
Pia Kivisäkk, Becky C. Carlyle, Thadryan Sweeney, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 38
Plasma biomarkers for neurodegenerative disorders: ready for prime time?
Wasiu Gbolahan Balogun, Henrik Zetterberg, Kaj Blennow, et al.
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 2, pp. 112-118
Open Access | Times Cited: 34
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective
Stefano Salvioli, Maria Sofia Basile, Leonardo Bencivenga, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102044-102044
Open Access | Times Cited: 32
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 13
A comparison of p‐tau assays for the specificity to detect tau changes in Alzheimer's disease
Shorena Janelidze, Nicholas J. Ashton, Anna Orduña Dolado, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access | Times Cited: 1
Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
Chiara Villa, Marialuisa Lavitrano, Elena Salvatore, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 61-61
Open Access | Times Cited: 62
Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
Kun Zou, Mohammad Abdullah, Makoto Michikawa
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 85-85
Open Access | Times Cited: 61
Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals
Jasmeer P. Chhatwal, Aaron P. Schultz, Yifan Dang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
Simon Thebault, Ronald A. Booth, Carolina Rush, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 52
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
Daniel Alcolea, Constance Delaby, Laia Muñoz, et al.
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 92, Iss. 11, pp. 1206-1214
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top